AZD1656
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Glucokinase activators (GKAs) are newly drug class proposed for diabetes treatment. This systematic review aimed to assess the…
To study the effect of exogenous i.m. glucagon on recovery from controlled insulin‐induced hypoglycaemia in patients with type 2…
Glucokinase activators (GKAs), such as AZD1656, are designed as antihyperglycemic agents for diabetics and can cause dose…
Glucokinase plays a central role in glucose homeostasis and small molecule activators of the glucokinase enzyme have been the…